Pharma Deko Plc (NGX: PHARMDEKO)

Market Cap	396.98M
Revenue (ttm)	469.58M
Net Income (ttm)	-141.61M
Shares Out	216.93M
EPS (ttm)	-0.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	1.830
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 15, 2024

About Pharma Deko

Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. It operates through three segments: Pharma, Consumer, and Contract. The company offers pharmaceutical products, such as Vitacee syrups and drops, Pharmadec syrups and drops, Brett mouthwash, Hexedene oral care medication, Parkalin range of cough syrup, Parkaling Pediatrics, Revitone Blood Tonic, Salins Liniment, Antasil tablets, Omepraz capsules, and Parkaprim tablets and suspension; and Sparxin, Pidiclox dry powder and capsules, ...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 70
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: PHARMDEKO

Financial Performance

In 2022, Pharma Deko's revenue was 469.58 million, a decrease of -6.75% compared to the previous year's 503.55 million. Losses were -141.61 million, 102.9% more than in 2021.